secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cardiff Oncology, Inc. (CRDF)
CIK:        0001213037
Form:       8-K
Filed at:   2026-02-25T23:59:59+00:00
Accession:  0001193125-26-068668
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cardiff Oncology furnishes Feb 2026 corporate presentation; no material news
----------------------------------------------------------------------------

- Corporate slide presentation furnished as Exhibit 99.1 for investor meetings.
- Presentation highlights onvansertib development pipeline and opportunity.
- No financial results, guidance, or operational milestones disclosed.
- Routine Regulation FD disclosure; no material changes to business.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1213037/000119312526068668/0001193125-26-068668-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1213037/000119312526068668/crdf-20260225.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-068668

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer